June 2, 2011

Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the Jefferies 2011 Global Healthcare Conference on June 9, 2011

SAN DIEGO, June 2, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that the company's President and CEO Ted Schroeder will present the company's corporate overview on Thursday, June 9, 2011 at 1:30pm Eastern Time (10:30am Pacific Time) during the Jefferies 2011 Global Healthcare Conference at the Grand Hyatt Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 90 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. In January 2011, Cadence commercially launched OFIRMEV™ (acetaminophen) injection, an intravenous formulation of acetaminophen, in the U.S. ¬†For more information about Cadence, please visit www.cadencepharm.com.

Contacts:

William R. LaRue


SVP & Chief Financial Officer


Cadence Pharmaceuticals, Inc.


858-436-1400



SOURCE Cadence Pharmaceuticals, Inc.

News Provided by Acquire Media


Close window | Back to top

Copyright 2014 Cadence Pharmaceuticals, Inc.